cinacalcet has been researched along with Vascular Calcification in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 18 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayach, T; El-Husseini, A; Elyamny, M; Kakani, E | 1 |
| Hamano, T; Lim, K; Thadhani, R | 1 |
| Hamano, T | 1 |
| Cheng, PM; Chow, KM; Kwan, BC; Leung, CB; Li, PK; Pang, WF; Szeto, CC | 1 |
| Abdelrahman, M; Abdulkader, M; Algareeb, A; Awn, NM; Karkar, A; Mushtaque, F; Nassar, M; Qadi, Y; Sabry, A; Shaheen, FA; Sinha, AK; Souqiyyeh, MZ; Taha, MI | 1 |
| Hénaut, L; Larsson, TE; Massy, ZA; Vervloet, MG | 1 |
| Yokoyama, K | 1 |
| Inaba, M | 1 |
| Ballarín, J; Bover, J; Cozzolino, M; daSilva, I; del Carpio, J; Lescano, P; Ruiz-García, C; Ureña, P | 1 |
| Martínez, AI; Milán, JA; Salgueira, M | 1 |
| Inoue, T; Kikuta, T; Sato, T; Suzuki, H; Tsuda, M; Uchida, K; Watanabe, Y | 1 |
| Akizawa, T; Mizobuchi, M; Nakazawa, A | 1 |
| Hu, B; Hu, P; Lu, L; Qin, YH; Wang, J; Xuan, Q | 1 |
| Couttenye, MM; Janssen van Doorn, K; Van Noten, C; Vermander, E; Verpooten, GA; Vlayen, S | 1 |
| Behets, GJ; D'Haese, PC; De Schutter, TM; Jung, S; Neven, E; Querfeld, U | 1 |
| Floege, J; Goodman, WG; Hawley, CM; Pedagogos, E; Pétavy, F; Raggi, P; Reiner, M; Ureña-Torres, PA | 1 |
| Goldsmith, D; Leonard, O; Spaak, J | 1 |
| Chudek, J; Kocełak, P; Olszanecka Glinianowicz, M; Zelaźnicka, M | 1 |
10 review(s) available for cinacalcet and Vascular Calcification
| Article | Year |
|---|---|
Pathogenesis and management of vascular calcification in CKD and dialysis patients.
Topics: Calciphylaxis; Calcitriol; Cardiovascular Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Comorbidity; Female; Humans; Incidence; Kidney Failure, Chronic; Male; Prognosis; Renal Dialysis; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vascular Calcification; Vitamin D | 2019 |
Vitamin D and Calcimimetics in Cardiovascular Disease.
Topics: Animals; Calcimimetic Agents; Cardiovascular Diseases; Cinacalcet; Clinical Trials as Topic; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Renal Insufficiency; Vascular Calcification; Ventricular Remodeling; Vitamin D; Vitamin D Deficiency; Vitamins | 2018 |
Mineral and bone disorders in conventional hemodialysis: Challenges and solutions.
Topics: Bone Density; Bone Density Conservation Agents; Calcium; Calcium-Regulating Hormones and Agents; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Fractures, Bone; Humans; Parathyroid Hormone; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Vascular Calcification | 2018 |
Calcium-sensing receptor activation in chronic kidney disease: effects beyond parathyroid hormone control.
Topics: Bone and Bones; Calcimimetic Agents; Cinacalcet; Gastrointestinal Tract; Homeostasis; Humans; Hyperparathyroidism, Secondary; Hypertension, Pulmonary; Naphthalenes; Parathyroid Hormone; Receptors, Calcium-Sensing; Renal Insufficiency, Chronic; Signal Transduction; Vascular Calcification; Water-Electrolyte Balance | 2014 |
[Vascular Calcification - Pathological Mechanism and Clinical Application - . The effect of cinacalcet on vascular calcification].
Topics: Animals; Calcimimetic Agents; Cardiovascular Diseases; Cinacalcet; Disease Progression; Humans; Naphthalenes; Randomized Controlled Trials as Topic; Receptors, Calcium-Sensing; Renal Insufficiency, Chronic; Vascular Calcification | 2015 |
Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism.
Topics: Calcimimetic Agents; Cinacalcet; Electrocardiography; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Parathyroid Hormone; Renal Dialysis; Vascular Calcification | 2016 |
[Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Advances in treatment of CKD-MBD].
Topics: Bone Diseases, Metabolic; Chronic Disease; Cinacalcet; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Klotho Proteins; Lanthanum; Membrane Proteins; Naphthalenes; Vascular Calcification; Vitamin D | 2011 |
Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease.
Topics: Animals; Calcimimetic Agents; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Diet; Endothelium, Vascular; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Kidney Transplantation; Male; Naphthalenes; Parathyroid Hormone; Phosphates; Polyamines; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification; Vitamin D; Vitamin D Deficiency | 2012 |
Regression of vascular calcification in chronic kidney disease - feasible or fantasy? a review of the clinical evidence.
Topics: Animals; Calcium; Cardiovascular Diseases; Cinacalcet; Humans; Naphthalenes; Phosphates; Primary Prevention; Renal Dialysis; Renal Insufficiency, Chronic; Secondary Prevention; Vascular Calcification | 2013 |
[Cinacalcet therapy and cardiovascular risk in hemodialysis patients].
Topics: Atherosclerosis; Cardiovascular Diseases; Causality; Cinacalcet; Comorbidity; Disease Progression; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Renal Dialysis; Risk Factors; Vascular Calcification | 2012 |
3 trial(s) available for cinacalcet and Vascular Calcification
| Article | Year |
|---|---|
Effect of cinacalcet treatment on vascular arterial stiffness among peritoneal dialysis patients with secondary hyperparathyroidism.
Topics: Aged; Blood Flow Velocity; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Peritoneal Dialysis; Pilot Projects; Prospective Studies; Pulsatile Flow; Treatment Outcome; Vascular Calcification; Vascular Stiffness | 2014 |
Does cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism, improve arterial stiffness in patients on continuous ambulatory peritoneal dialysis?
Topics: Administration, Oral; Ankle Brachial Index; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Vascular Calcification; Vascular Stiffness | 2011 |
Protocol adherence and the progression of cardiovascular calcification in the ADVANCE study.
Topics: Aged; Cinacalcet; Disease Progression; Female; Humans; Hyperparathyroidism, Secondary; Male; Medication Adherence; Middle Aged; Naphthalenes; Renal Dialysis; Renal Insufficiency, Chronic; Vascular Calcification; Vitamin D | 2013 |
5 other study(ies) available for cinacalcet and Vascular Calcification
| Article | Year |
|---|---|
Trends of elevated parathormone serum titers in hemodialysis patients on intensive therapy for bone disease: a multicenter study.
Topics: Adult; Aged; Biomarkers; Bone Diseases, Metabolic; Chelating Agents; Cinacalcet; Cost-Benefit Analysis; Dietary Supplements; Drug Costs; Female; Humans; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Saudi Arabia; Time Factors; Treatment Outcome; Up-Regulation; Vascular Calcification; Vitamin D | 2014 |
Importance of abnormal bone metabolism in the acceleration of atherosclerosis in hemodialysis patients.
Topics: Atherosclerosis; Bone Resorption; Calcimimetic Agents; Calcium; Cinacalcet; Disease Progression; Humans; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Vascular Calcification | 2015 |
Regression of vascular calcification in a patient treated with cinacalcet: a case report.
Topics: Breast; Calcimimetic Agents; Calcitriol; Calcium Carbonate; Chelating Agents; Cinacalcet; Drug Therapy, Combination; Female; Graft Rejection; Hand; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Mammography; Middle Aged; Naphthalenes; Nephritis, Interstitial; Phosphorus; Polyamines; Renal Dialysis; Reoperation; Sevelamer; Vascular Calcification | 2011 |
Maximal conservative therapy of calcific uremic ateriolopathy.
Topics: Arterioles; Calcimimetic Agents; Chelating Agents; Cinacalcet; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hyperbaric Oxygenation; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Negative-Pressure Wound Therapy; Renal Dialysis; Thiosulfates; Treatment Outcome; Uremia; Vascular Calcification | 2012 |
Restoration of bone mineralization by cinacalcet is associated with a significant reduction in calcitriol-induced vascular calcification in uremic rats.
Topics: Animals; Calcification, Physiologic; Calcitriol; Calcium; Cinacalcet; Hyperparathyroidism; Male; Naphthalenes; Rats; Rats, Sprague-Dawley; Uremia; Vascular Calcification; Vitamins | 2012 |